{"id":"W4407150890","doi":"10.1038/s41591-024-03485-7","title":"Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Institute of Cancer Research; University of Alberta; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Daratumumab; Multiple myeloma; Lenalidomide; Internal medicine; Hazard ratio; Bortezomib; Clinical endpoint; Transplantation; Surgery; Oncology; Confidence interval; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001927942,0.0006533087,0.002319566,0.0004761569,0.0004684215,0.00005205115,0.0003425079,0.0005457548,0.0001403886],"category_scores_gemma":[0.005550656,0.0003223925,0.0004255638,0.0007093492,0.0007401695,0.0001167657,0.00003593934,0.001241931,0.000004439737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001609697,"about_ca_system_score_gemma":0.0006089568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005840383,"about_ca_topic_score_gemma":0.0005442391,"domain_scores_codex":[0.9959057,0.0004494016,0.001040917,0.0008444616,0.0008589154,0.0009005793],"domain_scores_gemma":[0.9903121,0.007984816,0.0002092516,0.0007000834,0.0002945372,0.0004991995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9661973,0.0006506706,0.0002354001,0.0005326163,0.001685851,0.0006859354,0.001103831,0.000002318667,0.002858795,0.0002283773,0.008222703,0.01759617],"study_design_scores_gemma":[0.9682754,0.002157693,0.0005773299,0.001104511,0.002750717,0.0001761559,0.0002820952,0.004183343,0.005049441,0.0002003765,0.01495274,0.0002902121],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8901005,0.03393024,0.01298825,0.03398827,0.002273348,0.02355122,0.0008200839,0.0003348711,0.002013233],"genre_scores_gemma":[0.9857726,0.003890158,0.001255738,0.002807766,0.000989143,0.001686795,0.0009878611,0.00006484074,0.002545105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09567211,"threshold_uncertainty_score":0.9999228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03095167995952319,"score_gpt":0.3699476036177096,"score_spread":0.3389959236581864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}